Aggregation and Structural Assessments
Structural Assessments and Proactive Aggregation Monitoring During early drug development, it is critical to determine if your biologic protein is prone to self-association. Protein aggregation can cause activity loss of the drug substance and post immunogenicity risks on administration, threatening your drug development process. Formulation, processing, and contact material changes have the potential to trigger […]
Aggregation and Structural Assessments Read More »